JDD HighlightsJDD WebinarsThe LatestVideo Abstract

What’s New from CeraVe (Xerosis Management) and La Roche-Posay (Atopic Dermatitis Management in Diverse Patients)

By December 8, 2025December 11th, 2025No Comments

JDD Multimedia

What’s New from CeraVe (Xerosis Management) and La Roche-Posay (Atopic Dermatitis Management in Diverse Patients)

Join Dr. Zoe Diana Draelos, MD, as she presents data on over-the-counter product innovations from L’Oréal Dermatological Beauty’s trusted brands: CeraVe and La Roche-Posay

Dr. Draelos will discuss Xerosis Management and Barrier Repair in Mature Skin and how a CeraVe Ceramide and NMF-Containing Lotion restores hydration​ to healthy, young levels to relieve Mature Xerosis symptoms.

Dr. Draelos will also highlight new data from a study that Evaluated Natural Moisturizing Factors in ethnically diverse patients with Atopic Dermatitis following a Prebiotic Skincare regimen from La Roche-Posay.

Faculty

Zoe Diana Draelos, MD
Research & Clinical Board Certified Dermatologist
Dermatology Consulting Services PLLC
High Point, North Carolina

Watch On Demand

“Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care

| Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…

The PASI Paradigm Shift: How Higher Clinical Trial Endpoints Are Reshaping Dermatology

| Dermatology Podcast Archives, Featured Articles, Latest News, Podcast, Podcast Highlights | No Comments
Remember when PASI 75 was the gold medal? Today, it barely makes the podium. In this episode of the JDD Podcast, host Dr. Adam Friedman welcomes Dr. James Song for…

(P)Steroids & the Psyche: The Problems Nobody Put on the Prescription Label

| Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Guest: Dr. Lucinda Whitney When corticosteroid risks come up, most clinicians immediately think about osteoporosis, hyperglycemia, infection risk, or adrenal suppression. But what about the organ sitting between the ears?…

Leave a Reply